Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

- Check23 days agoChange DetectedRemoved a generic government funding status notice from the page. The study details, contacts, and locations remain unchanged.SummaryDifference0.3%

- Check38 days agoChange DetectedThe record for NCT02988817 now includes posted results, with Results First Submitted on 2022-11-07 and Results First Posted on 2023-01-05, and a last update on 2023-08-01. The page’s results section updates the outcome data and status history.SummaryDifference0.3%

- Check66 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check73 days agoChange Detected- Added: Revision: v3.1.0 - Removed: Genetic and Rare Diseases Information Center resources: Ovarian cancer; Revision: v3.0.2SummaryDifference0.2%

- Check88 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.